The FDA paused Moderna's norovirus vaccine trial due to a neurological side effect. New U.S. health secretary Robert F.
LANSING, Mich. (WILX) - Roughly one-tenth of the workforce at the Centers for Disease Control and Prevention are expected to ...
Moderna's norovirus vaccine trial paused due to a rare neurological effect, Citadel's short position in GSK, bird flu response issues during Trump's term, WHO's call for alcohol warning labels, and ...
In its fourth-quarter earnings report, Moderna’s revenue was down substantially from 2023. Separately, media reports reveal ...
19hon MSN
Vaccine maker Moderna had no Valentine’s Day chocolates for investors when its financial results came out Friday. The company ...
Moderna’s norovirus vaccine trial placed on FDA hold over reported case of Guillain-Barré syndrome
A trial of Moderna’s norovirus vaccine in the U.S. has been put on hold by the FDA over a reported case of neurological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback